戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ect on beta-actin or GAPDH (glyceraldehyde-3-phosphate dehydrogenase).
2 anufacturer control, GAPDH (glyceraldehyde-3-phosphate dehydrogenase).
3 inase and the rate-limiting enzyme glucose-6-phosphate dehydrogenase.
4 rginine deiminase ArcA, and glyceraldehyde 3-phosphate dehydrogenase.
5 sphate transport system and an sn-glycerol-3-phosphate dehydrogenase.
6 ific glycolytic proteins such as d-glucose-6-phosphate dehydrogenase.
7  a mutation of G6PD, which encodes glucose-6-phosphate dehydrogenase.
8 aminonicotinamide, an inhibitor of glucose-6-phosphate dehydrogenase.
9 within the endoplasmic reticulum by hexose-6-phosphate dehydrogenase.
10 ds to decreased activity of glyceraldehyde 3-phosphate dehydrogenase.
11 -synuclein, synapsin-I, and glyceraldehyde-3-phosphate dehydrogenase.
12  derived from the metabolic enzyme glucose-6-phosphate dehydrogenase.
13 he major apoptotic effector glyceraldehyde-3-phosphate dehydrogenase.
14 ncode the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase.
15 endoplasmic reticulum by the enzyme hexose-6-phosphate dehydrogenase.
16 codes the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase.
17 e dehydrogenase and heat-denatured glucose-6-phosphate dehydrogenase.
18 gresses from the host cell, glyceraldehyde-3-phosphate dehydrogenase 1 (GAPDH1), which is primary a g
19 malate/oxaloacetate shuttle and a glycerol-3-phosphate dehydrogenase 1(Gpd1p)-dependent shuttle are a
20 d with the PTS2-containing enzyme Glycerol-3-phosphate dehydrogenase 1, Gpd1.
21 ruvate dehydrogenase kinase 4 and glycerol 3-phosphate dehydrogenase 1, was acutely induced by a sing
22  in a conserved amino acid of the glycerol-3-phosphate dehydrogenase 1-like (GPD1-L) gene.
23      Here, we identify the enzyme glycerol-3-phosphate dehydrogenase 1-like (GPD1L) as a novel regula
24  of the mature miRNA, derepresses glycerol-3-phosphate dehydrogenase 1-like enzyme (GPD1L), a hypoxia
25 Recently, a novel mutation in the glycerol-3-phosphate dehydrogenase 1-like gene (GPD1-L) disrupted t
26  blocked the mutant A280V GPD1-L (glycerol-3-phosphate dehydrogenase 1-like) effect on reducing I(Na)
27 dentified by mass spectrometry as glycerol-3-phosphate dehydrogenase 2 (Gpd2).
28 lciparum , the bifunctional enzyme glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase (PfGlu
29  inhibition of the parasite enzyme glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, a key
30 thway by ADPr inhibition of glyceraldehyde-3-phosphate dehydrogenase, a central enzyme of glycolysis.
31  for the nonphosphorylating glyceraldehyde-3-phosphate dehydrogenase, a cytosolic enzyme whose role i
32 rs of Plasmodium falciparum glyceraldehyde-3-phosphate dehydrogenase, a validated target for the trea
33 hibited cylcooxgenase-2 and glyceraldehyde 3-phosphate dehydrogenase activity and triggered significa
34 by inducing maximal mitochondrial glycerol-3-phosphate dehydrogenase activity in rat liver while havi
35                                      Glucose phosphate dehydrogenase activity that gives rise to NADP
36 ement mediating selection for high glucose-6-phosphate dehydrogenase activity.
37 as also capable of inducing glyceraldehyde-3-phosphate dehydrogenase aggregation, but chondroitin sul
38 eS cluster binding, such as glyceraldehyde-3-phosphate dehydrogenase, aldehyde dehydrogenase, aconita
39 no acids) of serum albumin, glyceraldehyde-3-phosphate dehydrogenase, aldolase, and aspartate aminotr
40  stained with antibodies to glyceraldehyde-3-phosphate dehydrogenase, aldolase, phosphofructokinase,
41 A6, clathrin heavy chain 1, glyceraldehyde-3-phosphate dehydrogenase, alpha-enolase, filamin-A, and h
42 olism (triosephosphate isomerase, glycerol-3-phosphate-dehydrogenase, alpha enolase and L-lactate deh
43 f Hsp70 proteins), Tdh2/3p (glyceraldehyde-3-phosphate dehydrogenase, an RNA-binding protein), Pdc1p
44                                     Hexose-6-phosphate dehydrogenase and 11 beta-hydroxysteroid dehyd
45  Two NAD-dependent dehydrogenases (glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydroge
46 homeostasis, which is regulated by glucose-6-phosphate dehydrogenase and AMP kinase.
47 on of the secretory protein glyceraldehyde-3-phosphate dehydrogenase and ATP synthase subunit alpha i
48 ncluding nonphosphorylating glyceraldehyde-3-phosphate dehydrogenase and beta-glucosidase.
49          Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/a
50 s response, especially the roles of hexose-6-phosphate dehydrogenase and ER-anchored RING finger E3 l
51 oplast-targeted Plasmodium yoelii glycerol 3-phosphate dehydrogenase and glycerol 3-phosphate acyltra
52 es that catalyze their synthesis, glycerol-1-phosphate dehydrogenase and heptaprenylglyceryl phosphat
53 ntent of glycolytic enzymes glyceraldehyde 3-phosphate dehydrogenase and pyruvate dehydrogenase subun
54 olving conversion to N(tz) ADPH by glucose-6-phosphate dehydrogenase and reoxidation to N(tz) ADP(+)
55 ncreased ability to degrade glyceraldehyde-3-phosphate dehydrogenase and ribonuclease A when the reac
56 sed ability to degrade both glyceraldehyde-3-phosphate dehydrogenase and ribonuclease A, substrates f
57 are sensitive to oxidation, glyceraldehyde-3-phosphate dehydrogenase and the sodium-potassium ATPase,
58                    Evaluations for glucose-6-phosphate dehydrogenase and thiopurine S-methyltransfera
59 hosphate dehydrogenase, and glyceraldehyde-3-phosphate dehydrogenase) and their respective genetic va
60 glycerol synthesis gene, gpd1(+) (glycerol-3-phosphate dehydrogenase), and is independent of actin ca
61 l polymorphisms (ie, hemoglobin S, glucose-6-phosphate dehydrogenase, and alpha-thalassemia) were the
62 lucose 6-phosphate dehydrogenase, glycerol 3-phosphate dehydrogenase, and glucose oxidase.
63 mes (catechol-O-methyltransferase, glucose-6-phosphate dehydrogenase, and glyceraldehyde-3-phosphate
64 s including Tau, ubiquitin, glyceraldehyde-3-phosphate dehydrogenase, and glycosaminoglycans are rout
65 ce loci, glpABC, the anaerobic sn-glycerol-3-phosphate dehydrogenase, and plsB, an sn-glycerol-3-phos
66 el such actin, tubulin, and glyceraldehyde-3-phosphate dehydrogenase are frequently used as endogenou
67 ycerol-3-phosphate shuttle (Gut2, glycerol-3-phosphate dehydrogenase) are novel longevity factors in
68  stable mRNAs (e.g., GAPDH [glyceraldehyde-3-phosphate dehydrogenase]) are rapidly degraded.
69 d soluble recombinant sperm glyceraldehyde-3-phosphate dehydrogenase as a heterotetramer with the Esc
70 ntify the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase as a potent inhibitor of caspase
71 ified glucose transport and glyceraldehyde-3-phosphate dehydrogenase as the most selective antiparasi
72      We found that the HKGs glyceraldehyde-3-phosphate dehydrogenase, beta actin and adenosine tripho
73 tially reduced the inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal and malon
74 fied for the reaction catalyzed by glucose-6-phosphate dehydrogenase by comparing the 1-(13)C KIE wit
75 were silenced or up-regulated for sorbitol-6-phosphate dehydrogenase by using the CaMV35S promoter to
76 Transgenic plants with suppressed sorbitol-6-phosphate dehydrogenase compensated by accumulating sucr
77 nd that the glycolytic enzyme glyceraldehyde phosphate dehydrogenase constitutes a major cellular hem
78 olytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd).
79        Other abnormal hemoglobins, glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase d
80 idence interval {CI}, 0.52-0.90]), glucose-6-phosphate dehydrogenase deficiency in female children (R
81                                    Glucose-6-phosphate dehydrogenase deficiency serves as a prototype
82 ssemia, 0.3%; ABO group, 0.3%; and glucose-6-phosphate dehydrogenase deficiency, 0.5%) and the new po
83 eurotoxicity, such as prematurity, glucose-6-phosphate dehydrogenase deficiency, or hypoxia-ischemia.
84 alocytosis and two common forms of glucose-6-phosphate dehydrogenase deficiency.
85 relation with sickle cell trait or glucose-6-phosphate-dehydrogenase deficiency was observed.
86 pecies, the heparin-induced glyceraldehyde-3-phosphate dehydrogenase early oligomers might come in us
87 ncoded by glpK and suggest that a glycerol-3-phosphate dehydrogenase encoded by the upstream gpdABC o
88      Conditional expression of the glucose-6-phosphate dehydrogenase-encoding gene zwf, shown here to
89                      Patients with glucose-6-phosphate dehydrogenase enzyme activity of less than 70%
90 licated falciparum malaria, normal glucose-6-phosphate dehydrogenase enzyme levels, and hemoglobin le
91 D or another oxidative PPP enzyme, glucose-6-phosphate dehydrogenase, exhibit non-immune hemolytic an
92 te for an enzyme, F(420)-dependent glucose-6-phosphate dehydrogenase (Fgd), found in few bacterial ge
93 er coenzyme for an F(420)-specific glucose-6-phosphate dehydrogenase (Fgd).
94 nly mediated by loss of a specific glucose-6-phosphate dehydrogenase (FGD1) or its deazaflavin cofact
95 ly oligomers present in the glyceraldehyde-3-phosphate dehydrogenase fibrillation pathway promote alp
96 e excess of ALDH3A1 also protected glucose-6-phosphate dehydrogenase from inactivation because of dir
97 redoxin reductase (TR), and glyceraldehyde-3-phosphate dehydrogenase (G3PD) activities, as well as th
98 ldolase A and an isoform of glyceraldehyde 3-phosphate dehydrogenase (G3PDH) showed elevated oxidatio
99 ox polypeptide, beta-actin, glyceraldehyde 3-phosphate dehydrogenase (G3PDH), annexin A2, triose phos
100 itochondrial glutathione (GSH) and glucose 6-phosphate dehydrogenase (G6-PD) was restored by SAC trea
101 iphenyltetrazolium bromide] (MTT), glucose-6-phosphate dehydrogenase (G6DP), and calcein AM and ethid
102  isocitrate dehydrogenase (IDH) or glucose-6-phosphate dehydrogenase (G6PD) activity in a single gene
103                                    Glucose-6-phosphate dehydrogenase (G6PD) activity is essential for
104             ATM activation induces glucose-6-phosphate dehydrogenase (G6PD) activity, the limiting en
105                      Unexpectedly, Glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate de
106 xidation of G6P in the presence of glucose-6-phosphate dehydrogenase (G6PD) and nicotinamide adenine
107 tion, suggesting that intranuclear glucose-6-phosphate dehydrogenase (G6PD) can control NOX4 activity
108 ependent haemolysis in people with glucose-6-phosphate dehydrogenase (G6PD) deficiencies have limited
109                   Individuals with glucose 6-phosphate dehydrogenase (G6PD) deficiency are at risk fo
110 halassaemia, ABO blood groups, and glucose-6-phosphate dehydrogenase (G6PD) deficiency encoded by the
111                                    Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common hu
112                                    Glucose-6-phosphate dehydrogenase (G6PD) deficiency is believed to
113                                    Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most co
114                                    Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most co
115                                    Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most co
116  The global prevalence of X-linked glucose-6-phosphate dehydrogenase (G6PD) deficiency is thought to
117  by haemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
118 risk factors, and we also assessed glucose-6-phosphate dehydrogenase (G6PD) enzyme activity.
119                  The inhibition of glucose-6-phosphate dehydrogenase (G6PD) expression by arachidonic
120 hondria, whereas chloroquine and a glucose-6-phosphate dehydrogenase (G6PD) inhibitor affected the cy
121                                    Glucose-6-phosphate dehydrogenase (G6PD) is a key enzyme in the pe
122          The reaction catalyzed by glucose-6-phosphate dehydrogenase (G6PD) is the first, rate-limiti
123                                    Glucose 6-phosphate dehydrogenase (G6PD) is the most common defici
124                                    Glucose-6-phosphate dehydrogenase (G6PD) is the principal source o
125                                    Glucose-6-phosphate dehydrogenase (G6PD) is the rate-limiting enzy
126                                    Glucose-6-phosphate dehydrogenase (G6PD) modulates vascular functi
127 roscopy and had normal function of glucose-6-phosphate dehydrogenase (G6PD) on colorimetric quantific
128 s exacerbated in erythrocytes from glucose-6-phosphate dehydrogenase (G6PD) patients and rescued by a
129                                    Glucose-6-phosphate dehydrogenase (G6PD) regulates production of t
130 ing ATM or its downstream effector glucose 6-phosphate dehydrogenase (G6PD) sensitizes AML cells to F
131                                    Glucose-6-phosphate dehydrogenase (G6PD) status was determined usi
132 ivo, pharmacological inhibition of glucose-6-phosphate dehydrogenase (G6PD) to decrease NADPH levels
133 tive capacity by overexpression of glucose-6-phosphate dehydrogenase (G6PD), a key enzyme for NADPH b
134  necessary for NET release because glucose-6-phosphate dehydrogenase (G6PD), an important enzyme from
135 ession and enzymatic activities of glucose-6-phosphate dehydrogenase (G6PD), glutathione reductase, a
136 rial pathogen Pseudomonas syringae Glucose-6-phosphate dehydrogenase (G6PD), the key enzyme of the ox
137                  Here we show that glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme
138 ity of another cytoplasmic enzyme, glucose-6-phosphate dehydrogenase (G6PD), was also measured.
139 gulates stress tolerance by activating Glc-6-phosphate dehydrogenase (G6PD), which is essential for m
140 lase (HDAC) inhibitors (HDACis) in glucose-6-phosphate dehydrogenase (G6PD)-deficient cells reinstate
141 NADPH by impairing the activity of glucose 6-phosphate dehydrogenase (G6PD).
142 lectively enhance transcription of glucose 6-phosphate dehydrogenase (G6PD).
143                       In addition, glucose-6-phosphate-dehydrogenase (G6PD) deficiency, which is the
144 s in patients with a deficiency in glucose-6-phosphate dehydrogenase (G6PDd).
145 ake with a concomitant increase in glucose-6-phosphate dehydrogenase (G6PDH) activity, the key enzyme
146 ted the reactivation of aggregated glucose-6-phosphate dehydrogenase (G6PDH) by ClpB and its N-termin
147                                    Glucose-6-phosphate dehydrogenase (G6PDH) has been implicated in t
148 on enzymes such as NQO1 as well as glucose-6-phosphate dehydrogenase (G6PDH), a regulator of the pent
149 citrate dehydrogenase (NADP-ICDH), glucose-6-phosphate dehydrogenase (G6PDH), and, glutathione reduct
150 ibited high specificity for glyceraldehyde 3-phosphate dehydrogenase (GADPH) mRNA in live normal HEp-
151 n-1 (Hwp1); enolase (Enol); glyceraldehyde-3-phosphate dehydrogenase (Gap1); and phosphoglycerate kin
152  combined activities of the glyceraldehyde 3-phosphate dehydrogenases GapA/GapB and the malic enzymes
153        The cytosolic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPC) catalyzes a key reaction
154                 A cytosolic glyceraldehyde-3-phosphate dehydrogenase (GAPC) was identified to bind to
155 dial glycolytic isoforms of glyceraldehyde-3-phosphate dehydrogenase (GAPCp) in photosynthetic and he
156 ytosolic glycolytic enzymes glyceraldehyde-3-phosphate dehydrogenases (GAPCs) interact with the plasm
157 ly used housekeeping genes, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 18S ribosomal RNA (r
158  synergistic interaction of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and a major facilitator
159               Rab2 requires glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and atypical protein kin
160 supramolecular complex with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and phosphoribulokinase,
161 ming a ternary complex with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and phosphoribulokinase.
162 sibly acetylated, including glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Rpa1177, a putative
163  by the interaction between glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the E3 ubiquitin lig
164  by S-nitrosylation such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and thereby contributes
165  be the glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and triose-phosphate iso
166 proaches, we identified the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a C1q partner when ex
167 for RT-PCR and qrtPCR using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an endogenous control
168 mammalian glycolysis enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an NleB-interacting p
169   We found that I/R induces glyceraldehyde-3-phosphate dehydrogenase (GAPDH) association with mitocho
170 y nitroso compounds inhibit glyceraldehyde 3-phosphate dehydrogenase (GAPDH) by forming a reduction r
171                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from human pathogens Sta
172 single cell analysis of the glyceraldehyde 3 phosphate dehydrogenase (GAPDH) gene in human lymphocyte
173                             Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been found down-regu
174                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has been hypothesized as
175 form molecular targeting of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in human hepatocellular
176 ocation and accumulation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the nucleus has close
177                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a classical glycolyti
178                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a glycolytic enzyme t
179                             Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a glycolytic enzyme t
180                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional enz
181                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a ubiquitous and abun
182               NAD-dependent glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a ubiquitous enzyme i
183                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an abundant metabolic
184                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an enzyme best known
185                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is often used as a stabl
186 hway, the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mediates a novel cell de
187 lving nitric oxide (NO) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mediates cocaine's trans
188 , superoxide dismutase, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA with a concomitant
189 de is a structural mimic of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) on the sporozoite surfac
190                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) participates in a cell d
191 edly, the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) physically associates wi
192                             Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) plays a key regulatory f
193         METH also increases glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein in the crude ves
194 utoantigen protein p70, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) proteins and that the si
195 ambda (aPKCiota/lambda) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) recruitment to VTCs.
196                       Using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) silencing with small int
197 horesis, and phosphorylated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified by matrix
198 mino acids with identity to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was obtained.
199    Arginine kinase (AK) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were determined as the i
200 ble residues in the protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were examined.
201 lves interaction of nuclear glyceraldehyde-3-phosphate dehydrogenase (GAPDH) with apurinic/apyrimidin
202   Here, we demonstrate that glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a conventional glycolyt
203 receptors for Plg including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a cytoplasmic enzyme th
204 f the key glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a modification that inh
205                             Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a protein target used r
206                             Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), an important glycolytic
207 e, phosphoglycerate kinase, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and enolase, all of whi
208 o protect citrate synthase, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and the restriction end
209               Commonly used glyceraldehyde-3-phosphate dehydrogenase (Gapdh), beta-actin (Actb), or b
210 for total protein quantity, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), citrate synthase (CS),
211 s, creatine kinase (CK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), conformationally affect
212 n of the sulfhydryl enzyme, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in vitro and in tissues
213         Superoxide inhibits glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which activates major p
214 ons, nitroalkenes inhibited glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which contains a critic
215 vered that Escherichia coli glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which is not known to b
216 olvement in this process of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which participates in i
217 f the key glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
218  the L1 interaction partner glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
219 ribosomal protein L13a, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
220 osphoribulokinase (PRK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
221 nd nuclear translocation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
222 s: creatine kinase (CK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
223  (NO), which S-nitrosylates glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
224 s accumulate and inactivate glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
225 a-2 microglobulin (B2M) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
226    Tetrameric rabbit muscle glyceraldehyde 3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12) binds succe
227 ns of palmitoyl-CoA inhibit glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12) enzyme acti
228 f glycolytic enzymes (e.g., glyceraldehyde-3-phosphate dehydrogenase [GAPDH]) and transcription facto
229  protein (Ucp1) and mitochondrial glycerol-3-phosphate dehydrogenase (Gdm) result in mice with increa
230 et the histidine kinase and glyceraldehyde-3-phosphate dehydrogenase genes of B. dermatitidis and H.
231 s including c-myc, p21, and glyceraldehyde-3-phosphate dehydrogenase genes, indicating reduced promot
232     We studied the contribution of glucose-6-phosphate dehydrogenase (Glc-6-PD), an important regulat
233 gene for the conserved aerobic sn-glycerol-3-phosphate dehydrogenase GlpD.
234                                Sn-glycerol-3-phosphate dehydrogenase (GlpD) is an essential membrane
235 he integral membrane flavoenzyme, glycerol-3-phosphate dehydrogenase (GlpD), and the soluble redox fl
236 reaction utilizing three enzymes: glycerol 3-phosphate dehydrogenase, glycerol 3-phosphate acyltransf
237 s including alcohol dehydrogenase, glucose 6-phosphate dehydrogenase, glycerol 3-phosphate dehydrogen
238  phosphatase (PSP) motif fused to glycerol-3-phosphate dehydrogenase (GPD) domains.
239 ces cerevisiae has two homologous glycerol-3-phosphate dehydrogenases, Gpd1 and Gpd2, that are requir
240 e glycerol-producing PTS2 protein glycerol-3-phosphate dehydrogenase Gpd1p shows a tripartite localiz
241   Here we evaluate the effects of glycerol-3-phosphate dehydrogenase (Gpdh) and cytosolic malate dehy
242  of R269 lies at the surface of l-glycerol 3-phosphate dehydrogenase (GPDH) and forms an ion pair to
243 rginine or creatine kinase, glyceraldehyde-3-phosphate dehydrogenase (GPDH), calcium-binding protein,
244                                     Hexose-6-phosphate dehydrogenase (H6PD) generates NADPH, the cofa
245                                     Hexose-6-phosphate dehydrogenase (H6PD) is the initial component
246 hydrogenase type 1 (11betaHSD1) and hexose-6-phosphate dehydrogenase (H6PDH).
247                       Sperm glyceraldehyde-3-phosphate dehydrogenase has been shown to be a successfu
248 lbumin, choriogonadotropin, glyceraldehyde-3-phosphate dehydrogenase, Herceptin, and ReoPro.
249 xylase (ScOMPDC), and human liver glycerol 3-phosphate dehydrogenase (hlGPDH) for catalysis of reacti
250             The R269A mutation of glycerol-3-phosphate dehydrogenase (hlGPDH) results in a 9.1 kcal/m
251 r with the Escherichia coli glyceraldehyde-3-phosphate dehydrogenase in a ratio of 1:3 and have solve
252 -synuclein, synapsin-I, and glyceraldehyde-3-phosphate dehydrogenase in cultured hippocampal neurons,
253 nd formate, and overexpression of sorbitol-6-phosphate dehydrogenase in lactate dehydrogenase-deficie
254 tabolism via iodoacetate, a glyceraldehyde-3-phosphate dehydrogenase inhibitor, is sufficient to indu
255 f the pentose phosphate pathway by glucose-6-phosphate dehydrogenase inhibitors and siRNA suppressed
256                             Glyceraldehyde-3-phosphate dehydrogenase is a glycolytic enzyme that can
257 vity of its ancillary subunit-the glycerol-3-phosphate dehydrogenase-like protein.
258 l 3-phosphate by mitochondrial sn-glycerol 3-phosphate dehydrogenase (mGPDH) is a major pathway for t
259 normalization to 5 x 10(6) glyceraldehyde-3'-phosphate dehydrogenase mRNA copies, normalized PSA copi
260 substrate glycolaldehyde (GLY) by glycerol 3-phosphate dehydrogenase (NAD (+), GPDH) saturated with N
261  to the gpdC gene of the putative glycerol-3-phosphate dehydrogenase operon (gpdABC), based on the fi
262 observe changes in the activity of glucose-6-phosphate dehydrogenase or in the pentose phosphate path
263 of the Calvin cycle enzymes glyceraldehyde-3-phosphate dehydrogenase or ribulose-1,5-bisphosphate car
264      Cytosolic Oryza sativa glyceraldehyde-3-phosphate dehydrogenase (OsGAPDH), the enzyme involved i
265  and a member of the 4-hydroxy-l-threonine 4-phosphate dehydrogenase (PdxA) oxidative decarboxylase,
266 that inhibit Plasmodium falciparum glucose-6-phosphate dehydrogenase (PfG6PD).
267 iculum Ca2+-ATPase, mitochondrial glycerol 3-phosphate dehydrogenase, PGC1alpha, CoxII, and mitochond
268 tants deficient in PavA, CodY, and glucose-6-phosphate dehydrogenase pointing to the robustness of th
269 erochromatic) and the human glyceraldehyde-3-phosphate dehydrogenase promoter (euchromatic), we show
270 se, malate dehydrogenase 1, glyceraldehyde-3-phosphate dehydrogenase, proteoglycan 4, minichromosome
271 PDH) [small interfering RNA(glyceraldehyde 3-phosphate dehydrogenase)] reduces PLCbeta-mediated calci
272 e acyltransferase or GLY1-encoded glycerol-3-phosphate dehydrogenase restored 18:1 levels in HRT ssi2
273  somatic and sperm-specific glyceraldehyde-3-phosphate dehydrogenase revealed few differences at the
274 nding protein 2b (SAG0765), glyceraldehyde-3-phosphate dehydrogenase (SAG0823), and an iron-binding p
275 ediated by the nitric oxide-glyceraldehyde-3-phosphate dehydrogenase signaling pathway.
276   METHODS AND Patients with normal glucose-6-phosphate dehydrogenase status with symptomatic P. vivax
277 ockade of glycolysis at the glyceraldehyde 3-phosphate dehydrogenase step as the central metabolic ba
278 uation of glycolysis at the glyceraldehyde 3-phosphate dehydrogenase step due to the reduced availabi
279 rmediates before and at the glyceraldehyde 3-phosphate dehydrogenase step, promoting carbon overflow
280 tic intermediates after the glyceraldehyde 3-phosphate dehydrogenase step, thereby reducing carbon fl
281  glycolysis by blocking the glyceraldehyde 3-phosphate dehydrogenase step.
282 ailed analysis of the sperm glyceraldehyde-3-phosphate dehydrogenase structure revealed sites in the
283 ared with published somatic glyceraldehyde-3-phosphate dehydrogenase structures that could be exploit
284 gene, gpdA, encoding a homolog of glycerol-3-phosphate dehydrogenase subunit A, were upregulated (8-
285 p is a cytosolic NAD(+)-dependent glycerol 3-phosphate dehydrogenase that also localizes to peroxisom
286 peS6PDH encodes a NADPH-dependent sorbitol-6-phosphate dehydrogenase, the key enzyme for biosynthesis
287 stration that the resulting glyceraldehyde-3-phosphate dehydrogenase, the normal target of pentalenol
288 (1)H NMR spectroscopy using glyceraldehyde 3-phosphate dehydrogenase to trap the first-formed product
289 ibitor (dehydroepiandrosterone) of glucose-6-phosphate dehydrogenase together established redundancy
290 ints in central metabolism (Glyceraldehyde 3-phosphate dehydrogenase, transaldolase, alcohol dehydrog
291 olytic enzymes, aldolase A, glyceraldehyde 3-phosphate dehydrogenase, triose phosphate isomerase, and
292  glycolaldehyde (GA) catalyzed by glycerol-3-phosphate dehydrogenase were determined over a 2100-fold
293 oxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase were initially implicated in thi
294 osolic isocitrate dehydrogenase or glucose-6-phosphate dehydrogenase, which also produce cytosolic NA
295 a-actin, alpha-tubulin, and glyceraldehyde 3-phosphate dehydrogenase, which are usually used as contr
296 has >80% amino acid homology with glycerol-3-phosphate dehydrogenase, which is involved in NAD-depend
297 for the housekeeping enzyme glyceraldehyde-3-phosphate dehydrogenase, wild-type HSV infection reduced
298 lated lysine residue 184 in glyceraldehyde 3-phosphate dehydrogenase with glutamic acid, a malonyllys
299 er-expressing zwf gene (coding for glucose-6-phosphate dehydrogenase), WX-zwf, produced the highest g
300  on glucose has been attributed to glucose-6-phosphate dehydrogenase (Zwf1p) and a cytosolic aldehyde

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top